Platelet-derived growth factor and prostacyclin in kidney transplant rejection.
Sinzinger
H
H
Zidek
T
T
Foegh
M L
ML
D015121:6-Ketoprostaglandin F1 alpha / Q000032:analysis; D000804:Angiotensin II / Q000494:pharmacology; D003524:Cyclosporins / Q000494:pharmacology; D011464:Epoprostenol / Q000096:biosynthesis*; D006084:Graft Rejection; D006801:Humans; D066298:In Vitro Techniques; D007668:Kidney / Q000378:metabolism; D007672:Kidney Cortex / Q000378:metabolism; D007679:Kidney Medulla / Q000378:metabolism; D016030:Kidney Transplantation; D010982:Platelet-Derived Growth Factor / Q000494:pharmacology*; D011863:Radioimmunoassay; D013929:Thromboxane B2 / Q000032:analysis
D003524:Cyclosporins; D010982:Platelet-Derived Growth Factor; D000804:Angiotensin II; D013929:Thromboxane B2; D015121:6-Ketoprostaglandin F1 alpha; D011464:Epoprostenol